A Study of TAK-659 in Combination With Venetoclax for Adult Participants With Previously Treated Non-Hodgkin Lymphoma

NCT03357627 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Non-Hodgkin
Lymphoma, Large B-cell, Diffuse
Lymphoma, Follicular

Interventions

DRUG: TAK-659
DRUG: Venetoclax

Sponsor

Calithera Biosciences, Inc